VICTORY CAPITAL MANAGEMENT INC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 321 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
VICTORY CAPITAL MANAGEMENT INC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$10,685,151
+11.7%
279,716
+5.5%
0.01%
+9.1%
Q2 2023$9,561,832
+3.9%
265,091
+10.0%
0.01%
+10.0%
Q1 2023$9,204,210
-88.6%
241,011
-83.0%
0.01%
-89.2%
Q4 2022$80,533,757
+70.3%
1,415,356
+18.4%
0.09%
+69.1%
Q3 2022$47,277,000
-40.0%
1,195,686
-33.2%
0.06%
-38.9%
Q2 2022$78,761,000
+238.3%
1,790,044
+206.7%
0.09%
+291.3%
Q1 2022$23,280,000
-33.0%
583,676
-32.5%
0.02%
-28.1%
Q4 2021$34,748,000
-7.3%
864,173
-6.2%
0.03%
-13.5%
Q3 2021$37,466,000
-7.3%
921,001
+3.5%
0.04%
-5.1%
Q2 2021$40,418,000
-11.1%
890,069
-18.4%
0.04%
-17.0%
Q1 2021$45,459,000
-2.9%
1,090,398
-0.5%
0.05%
-9.6%
Q4 2020$46,802,000
+20.4%
1,095,791
-25.9%
0.05%
+4.0%
Q3 2020$38,859,000
-5.7%
1,478,670
-3.8%
0.05%
-10.7%
Q2 2020$41,202,000
+268.9%
1,536,807
+147.5%
0.06%
+522.2%
Q1 2020$11,170,000
+1253.9%
620,902
+1233.7%
0.01%
+800.0%
Q4 2019$825,000
+32.0%
46,556
+15.5%
0.00%0.0%
Q3 2019$625,000
-65.2%
40,317
-63.9%
0.00%
-75.0%
Q1 2019$1,797,000
+2.6%
111,610
-6.7%
0.00%0.0%
Q4 2018$1,751,000
-20.9%
119,670
-1.7%
0.00%
-20.0%
Q3 2018$2,213,000
+2.3%
121,790
-5.0%
0.01%0.0%
Q2 2018$2,164,000
-18.4%
128,250
-5.3%
0.01%
-16.7%
Q1 2018$2,652,000135,3600.01%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Third Security, LLC 19,305,403$233,209,00010.86%
BB BIOTECH AG 7,379,832$89,148,0003.13%
SENZAR ASSET MANAGEMENT, LLC 550,544$6,650,572,0001.72%
SNYDER CAPITAL MANAGEMENT L P 2,232,114$26,964,0001.69%
Sterling Global Strategies LLC 22,000$266,0000.98%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,290,024$112,223,0000.98%
MSD Partners, L.P. 965,000$11,657,0000.94%
DOHENY ASSET MANAGEMENT /CA 130,950$1,582,0000.81%
Bellevue Group AG 318,000$3,841,0000.69%
Taylor Wealth Management Partners 128,110$1,548,0000.69%
View complete list of HALOZYME THERAPEUTICS INC shareholders